Entering a New Era of Antihypertensive Therapy

Am J Kidney Dis. 2024 Mar;83(3):411-414. doi: 10.1053/j.ajkd.2023.09.009. Epub 2023 Nov 7.

Authors

Jordana B Cohen¹, Adam P Bress²

Affiliations

¹ Renal-Electrolyte and Hypertension Division, Philadelphia, Pennsylvania; Department of Biostatistics, Epidemiology, and Informatics, Philadelphia, Pennsylvania; Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania. Electronic address: jco@pennmedicine.upenn.edu.
² Intermountain Healthcare Department of Population Health Sciences, Spencer Fox Eccles School of Medicine, University of Utah, Salt Lake City, Utah.

PMID: 37939995
DOI: 10.1053/j.ajkd.2023.09.009

No abstract available

Publication types

Editorial
Comment

MeSH terms

Antihypertensive Agents* / therapeutic use
Humans
Hypertension* / drug therapy

Substances

Antihypertensive Agents